It has indirectly done so through its depressing effects on economic growth – and therefore on tax revenues. Brexit has…
The UK pharmaceutical industry is asking for more clarification post-brexit MHRA guidelines. Whilst Prime Minister Rishi Sunak and Labour party … Read…
Companies with authorization in certain regions, including the EU and U.S., would be able to use their approvals to access…
While it’s fair to say we would still experience issues with medicine supplies due to the global shortage of medicines,…
The UK’s drug regulator, the MHRA, has taken a hit in terms of capacity and funding post-Brexit, and could benefit…
The supply of over 50% of veterinary medicines to Northern Ireland is at risk of being discontinued after 2025 despite…
Over half (54%) of the surveyed healthcare industry professionals indicated that their sentiment towards Brexit had become more negative. Read More
Dive Brief: Great Britain is set to extend its acceptance of CE-marked medical devices for up to seven more years…
Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment The Swiss pharmaceutical…
The Nuffield Trust said a recent example of a product licensed in Great Britain but not Northern Ireland is a…